Form 8-K - Current report:
SEC Accession No. 0001104659-19-013133
Filing Date
2019-03-06
Accepted
2019-03-06 16:05:34
Documents
3
Period of Report
2019-03-06
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-5985_18k.htm 8-K 31043
2 EX-99.1 a19-5985_1ex99d1.htm EX-99.1 125215
3 EX-99.2 a19-5985_1ex99d2.htm EX-99.2 9537
  Complete submission text file 0001104659-19-013133.txt   167144
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 19662554
SIC: 2834 Pharmaceutical Preparations